MRI T1 Contrast-Enhanced Signal Intensity Is a Prognostic Indicator of Imatinib Therapy in Desmoid-Type Fibromatosis

OBJECTIVE: To investigate the efficiency of pre-therapy magnetic resonance imaging (MRI) features in predicting the prognosis of desmoid-type fibromatosis patients treated with imatinib. MATERIALS AND METHODS: A total of 38 desmoid-type fibromatosis patients treated with imatinib were collected in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Hui Ci, Xu, Shi Xing, Li, Xiao Ting, Guan, Zhen, Li, Shu, Sun, Ying-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040797/
https://www.ncbi.nlm.nih.gov/pubmed/33854962
http://dx.doi.org/10.3389/fonc.2021.615986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040797/
https://www.ncbi.nlm.nih.gov/pubmed/33854962
http://dx.doi.org/10.3389/fonc.2021.615986

Ejemplares similares